Hydrogenated Soy Phosphatidylcholine (HSPC) – what it is and how it’s made
HSPC is a phospholipid derived from soybean lecithin that has undergone partial hydrogenation of its fatty‑acid chains. The goal is to raise the proportion of saturated fatty acids, which in turn raises the gel‑transition temperature (Tₘ) of the phospholipid bilayer and improves the physical stability of liposomal preparations.
---
Typical fatty‑acid makeup
| Fatty‑acid type | Representative species | Typical molar % in HSPC |
|-----------------|------------------------|------------------------|
| Saturated (C16:0, C18:0) | 1,2‑dipalmitoyl‑PC (DPPC) / 1,2‑distearoyl‑PC (DSPC) | ≈ 60–75 % |
| Monounsaturated (C18:1, C20:1) | 1,2‑oleoyl‑PC | ≈ 15–20 % |
| Polyunsaturated (C20:4, C22:6) | 1,2‑linoleoyl‑PC, 1,2‑arachidonoyl‑PC | ≈ 5–10 % |
| Other minor components (free fatty acids, lysophospholipids, cholesterol) | – | ≈ 5 % |
Why the numbers?
The “partial” hydrogenation typically converts about 30–50 % of the double bonds in the soybean PC mixture into single bonds. The remaining unsaturated species are largely the long‑chain ω‑6 and ω‑3 fatty acids that are naturally present in soybean lecithin. The exact ratio depends on the soybean source, the hydrogenation conditions, and the desired Tₘ.
---
Key physical characteristics
| Property | Typical value for HSPC |
|----------|------------------------|
| Gel‑transition temperature (Tₘ) | 55–65 °C (depending on the saturated‑fatty‑acid content) |
| Phase behavior at 37 °C | Mostly solid‑like (gel phase) – provides a rigid bilayer useful for subcutaneous liposomes |
| Stability | Reduced leakage, lower fusion propensity compared with unsaturated PCs |
---
Why you’ll see HSPC in drug formulations
| Application | Why HSPC is chosen |
|-------------|-------------------|
| Liposomal drugs (e.g., Doxil, pegylated liposomal doxorubicin) | High Tₘ gives the liposome a stable, non‑fusogenic core that protects the drug during storage and circulation. |
| Subcutaneous delivery | Solid‑like bilayers resist premature drug release at 37 °C and facilitate controlled, slow release. |
| Nanoparticle drug carriers | Saturated chains reduce membrane fluidity, which can enhance encapsulation efficiency and reduce burst release. |
---
Quick “cheat sheet” for the saturated PC portion
If you’re ever asked to break down the saturated part of an HSPC batch, you can say:
“The saturated PC fraction is primarily 1,2‑dipalmitoyl‑phosphatidylcholine (DPPC) and 1,2‑distearoyl‑phosphatidylcholine (DSPC). Together they make up about 60–75 % of the total phospholipid content, with the remainder being unsaturated species and minor lipids.”
---
Bottom line
Hydrogenated soy phosphatidylcholine is a mixture of soybean PC molecules that have been partially hydrogenated to increase the saturated‑fatty‑acid fraction. This gives HSPC its high phase‑transition temperature and the robust, stable bilayer properties that make it a cornerstone of many liposomal and subcutaneous drug delivery systems.